5th Floor, Brigade Towers,
Financial District, Gachibowli,
Hyderabad - 500032,
The market is segmented by Product( Reagents and Kits, Services, Others), Application, End-User, and Geography
Fastest Growing Market:
The shorter-expression time and structural modification are some of the major features of protein expression which is contributing to the growing demand for the same. Cell-free protein expression employs cell lysates for the production of the desired recombinant proteins, with the primary advantage of this technique being the aversion of workflow hurdles of maintaining cell culture or living cells. Cell lysates are produced via. the breakdown and use of cellular components of eukaryotic or bacterial cells. Currently, several cell-free protein expression systems are commercially available, based on E. coli, rabbit reticulocytes, wheat germs, human cell lines, and insect cells. In vitro protein expression system has significant advantages over living cell-based protein expression, including a shorter duration of the process, isotopic labeling of proteins, incorporation of non-natural amino acids, optimization of protein complexes, incorporation of non-natural amino acids, and cost-effectiveness. Furthermore, these techniques also enable the manufacture of proteins that are toxic to host cells in recombinant techniques.
Therefore, considering the significance of protein expression, the market studied is expected to grow over the forecast period.
Protein expression refers to the way in which proteins are modified, synthesized and regulated in living organisms. Protein research term is applicable to either the object of study or the laboratory techniques required to manufacture proteins. Proteins are regulated and synthesized depending upon the functional need in the host cell.
Report scope can be customized per your requirements. Click here.
The cell-free protein expression is well-established in the market, due to the acceptance of it and this protein expression is performed without the use of living cells. This technique has many advantages over other protein expression techniques and because of its advantages, it is widely used. Due to the advantages of cell-free protein techniques, such as increased speed, ability to express toxic proteins, ease of amino acid type selective labeling, among others, these are making this cell expression market to grow.
The applications of cell-free expression include high throughput screen for truncated proteins, making proteins that are toxic to expression hosts in vivo, expression of proteins with amino acids, and incorporation of post-translational modifications, among others. The latest trend in the field of cell-free expression research is protein nano-crystallography. This technology is capable of forming and characterizing stable protein microcrystals down to atomic resolution. This unique technology may increase the growth of the cell-free expression market, which in turn, is expected to boost the protein expression market.
To understand key trends, Download Sample Report
The protein expression market in the United States is currently the most progressive and lucrative in the world and holds the largest share of the overall global protein expression market. The United States protein expression market is driven by factors, such as investments in research activities, an increase in the usage of protein technologies, and the rapid evolution of the pharmaceutical industry in the region. Other factors driving the protein expression market in the United States include the presence of several companies in the region itself.
The increasing research intensity in the pharmaceutical sector of the United States is adding to the opportunities for growth of the market. In the United States, opportunities in the field of proteomics have further boosted the market. However, stringent FDA regulatory policies are hindering the growth of the protein expression market.
To understand geography trends, Download Sample Report.
The protein expression market is moderately competitive and is majorly dominated by global companies. Local players are also doing good business across various countries such as India and China. With the rising R&D activity in the pharmaceutical industry, new companies are entering the market studied and they are believed to hold a substantial share in the near future.
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Rising R&D Activity in the Pharmaceutical Sector
4.2.2 Escalation in the Biologics Market
4.2.3 Government Support for Proteomics and Genomics Research
4.3 Market Restraints
4.3.1 Stringent Regulation
4.3.2 Growing Competition Among the Vendors
4.4 Porter's Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION
5.1 By Product
5.1.1 Reagents and Kits
184.108.40.206 Cell-Free Expression
220.127.116.11 Bacterial Expression
18.104.22.168 Yeast Expression
22.214.171.124 Algal Expression
126.96.36.199 Insect Expression
188.8.131.52 Mammalian Expression
184.108.40.206 Other Expression Systems
5.2 By Application
5.3 By End-User
5.4.1 North America
220.127.116.11 United states
18.104.22.168 United Kingdom
22.214.171.124 Rest of Europe
5.4.3 Asia Pacific
126.96.36.199 South Korea
188.8.131.52 Rest of Asia-Pacific
5.4.4 Middle East and Africa
184.108.40.206 South Africa
220.127.116.11 Rest of Middle East and Africa
5.4.5 South America
18.104.22.168 Rest of South America
6. COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Agilent Technologies
6.1.2 Bio-Rad Laboratories Inc.
6.1.3 Merck KGaA
6.1.4 New England Biolabs, Inc.
6.1.5 Oxford Expression
6.1.6 Promega Corporation
6.1.7 Qiagen N.V
6.1.8 Takara Bio, Inc.
6.1.9 Thermo Fisher Scientific Inc.
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
** Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies, and Recent Developments